Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.

Hims alternatives: top 4 programs compared

If Hims isn't right for you — coverage, pricing, state availability, or program fit — these are the editorially-vetted alternatives we recommend. Editorial pick at #1.

Last reviewed: September 2026 · how we rank · original Hims review →

Editorial pick
HealthRX logo

HealthRX

from $99/mo

HealthRX: low-cost compounded GLP-1

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Compounded medication, not an FDA-approved branded GLP-1
  • Lowest price requires a 12-month commitment

We may earn a commission. Pricing on partner site is final.

Why we pick this: Highest-ranked Hims alternative on our 5-factor methodology score.

Enhance MD logo

Enhance MD

from $212/mo

Enhance MD: flat-rate GLP-1 weight-loss care

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Compounded telehealth program, not a branded FDA-approved product
  • Ongoing subscription rather than one-time

We may earn a commission. Pricing on partner site is final.

Oak logo

Oak

Oak weight-loss telehealth program

Off-Rx: no plan
Flaws but not dealbreakers (1)
  • Program details and pricing are not listed publicly; confirm on their site

We may earn a commission. Pricing on partner site is final.

Ro logo

Ro

from $145/mo
  • Best for insured patients
  • Best for clinical oversight

Ro Body — branded GLP-1 weight care program

Why we picked it

The insurance concierge actually files your prior authorization, which can drop the effective cost below $50/month when your plan covers GLP-1s. Named obesity-medicine leadership.

Who should skip

Skip if you are cash-pay only — Ro's value is the insurance work, and you pay for clinical depth you may not need.

Behavioral layer2/10
  • Dietitian
  • Curriculum
  • Community
  • Coach
  • Muscle
  • Off-Rx
Off-Rx: no plan
Flaws but not dealbreakers (3)
  • Not the cheapest entry point in the category
  • Not available in Louisiana or Alaska
  • Compounded medication availability varies by FDA shortage status

We may earn a commission. Pricing on partner site is final.

Why trust this comparison

Independent

No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.

Affiliate disclosure

Primary sources

Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.

Editorial methodology

Editorial-revenue separation

Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.

Editorial policy

Compare Hims head-to-head